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A fully-automated open in vitro diagnostics analyser is described.
It is based on a pipetting robot, robotic manipulator and modular
components. The paper examines the way the system was developed
and looks at future trends in in vitro automated systems.
Introduction
different recipients, microtitration plates, different wash
solutions and reagents, different incubation times with or
without shaking). An early example is the Zymate
Microplate Management System [4]. The first systems
were very bulky and required significantly more time for
integration into the laboratory environment [5].
It can now cost tens of millions of dollars to develop [6]
ifthe developer cannot spin-offfrom existing systems. This
paper examines the development process taking the
GENESIS RMP from Tecan as an example. In addition,
future trends and needs in automated in vitro diagnostic
analysis are discussed.
Since the first description of radioimmunoassays (RIAs)
[1], and especially in the last two decades, a large number
of immunoassays have been developed. There has been a
move away from radioisotope labelling for three main
reasons:
(1) Personal safety (although this is often exaggerated).
(2) Short half-life (and therefore shelf-life) of reagents.
(3) Unsuccessful attempts to automate RIA [2].
Nephelometric determinations of antigens have become
more popular because of new techniques (laser nephelo-
metry) and automation, but its sensitivity is limited and
it is not applicable to haptens. Homogeneous assays
(EMIT, CEDIA, FPIA) have also become popular, for
they can be handled much like ordinary chemical
determinations with corresponding automatic equipment.
However, the methodolog-y is not as sensitive as hetero-
geneous methods [3]. In addition, the tests are produced
commercially and analysts often wait a long time until
certain parameters are ready for commercial applications
(for example FT4, TSH, Troponin). This makes the
analyst dependent on the manufacturer and small volume
tests are not commercially viable.
In the past, RIA tests could easily be handled in the users’
laboratories by iodine labelling. Today ELISA (and to
some extent TRFIA) are the only methods that can be
custom-made with reasonable effort and sufficient pre-
cision. The success of the ELISA ’sandwich technique’ is
based on the fact that enzyme labelled antibodies against
the second antibody are commercially available. ELISA
is the current technique employed for small volume
parameters on a commercial basis.
To deal with a large variety of different ELISA tests,
however, a flexible instrument is necessary; an instrument
that is open, programmable by the user and able to handle
automatically a large number of different tests (with
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Development tools
After the initial phase of market research comes a process
of wish-driven thinking. Visions have next to be matched
to reality by writing the specifications of the analyser to
be developed There are many tools for this--for example
quality houses, requirements deployment and scoring
techniques [_7], but in many cases good common sense is
best. Internal and external communications have to be
encouraged to get a maximum ofinput about the desirable
and feasible characteristics of the analyser. For GENESIS
RMP, an advisory board composed of experts in the field
from different countries was consulted for each develop-
ment step of the system, starting with the specifications
and ending with the first serial production.
Once the specifications of the analyser have been defined,
implementation is the hardest, part. A development
schedule clearly helps to prevent deadlocks. However, a
common error in planning is assuming ’best case scenarios ’.
A realistic assessment of the time schedule is vital. Quicker
or slower than expected development times should ideally
be rare.
Frequent redesign meetings, involving all personnel
developing the analyser are important for focusing
everybody’s thinking onto the project. This is necessary,
since people tend to deviate from the fixed goal over time.
A redesign meeting is not an exam, but a means to get
everybody on board again, with the boat going in one
common direction (see figure 1).
Potential equipment failures and their effects on the
system and the surroundings (personnel and patient data)
are analysed and preventative measures devised during
the development phase.
The biggest surprise for most developers comes towards
the end of the development process, when hardware and
softwarehave to be combined. Extended (in-house) and
] (outside the plant) testing and debugging needs to be
done; ] testing involves checking the combination of
hardware and software in real-world conditions [9].
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Figure 1. The eect of flequent redesign meetings upon the
orientation of the development team. Each arrow represents a
member ofthe team. Over time, there is continuing risk ofdeviation
jr’ore the common goal. Ideally, each redesign meeting helps to
streamline the arrows. During a redesign meeting the common goal
direction can change.
System development and system description
Scoring of the analyser specifications gave the highest
ranking to the openness of the system; modularity was
second. In fact, modularity should make the system more
open, also servicing is easier.
The GENESIS RMP is a modular automated random-
access analyser based on a pipetting robot as platform. A
Cartesian robotic manipulator arm was chosen to allow
objects to be transported in the system. Although this
solution demanded a lot of space, it allowed objects like
microtitration plates (MTPs), deep-well plates and
reagent racks to be transported within the accessible work
space of the robotic arm. The system could still be
bench-top; its dimensions are 178 cm width, 77 cm depth
and 87 cm height (see figure 3). A liquid dispenser with
up to eight tips that can be equidistantly spaced between
each other from 9 to 38 mm, supports any liquid handling
movement from diverse sources to a variety ofdestinations
(figure 2). To guarantee complete performance ofELISAs
and agglutination assays, incubator/shaker, washer and
reader (with four possible wavelengths, for example 405,
450, 492, 620nm) are integrated components of the
system. In order to keep the system open to the user, these
can be exchanged.
Loading and discharging of reagents and consumables at
the beginning and at the end of a run are the only manual
interferences with the system, except for an eventual
refilling ofdisposable tips (the system uses either standard
Teflon(R)-coated steel-dispenser tips or disposable tips, or
any combination of the two). The fact that the system
needed to be bench-top size restricted the storing capacity
ofdisposable tips on the analyser. This is a typical example
ofthe kind ofcompromise necessary between two opposing
development features of equal ranking.
In the case of standard tips, overflow-washing of the tips
in a wash station can be programmed between each
change of dispensed solution to avoid cross-contamination.
The washing station comprises vertical columns with blind
cavities in the middle. Washing is achieved by positioning
the probe tip into the chamber and dispensing system
liquid through it. This flushes the inside of the tip and
Primary distribution
archiving tubes
secondary tubes
secondary tubes
secondary tubes
Primary distribution
secondary tubes
secondary tubes
secondary tubes
secondary tubes
Primary distribution
archiving tubes
secondary tubes
test tubes
test tubes
Primary tubes
test tubes
test tubes
test tubes
test tubes
Secondary tubes
test tubes
test tubes
test tubes
test tubes
Figure 2. The various pipetting strategies of the GENESIS
RMP. The term ’tube" is used for any liquid compartment
within the analyser worktable area. The system can work
directly Jiom (barcoded) primary tubes (10 to lZmm). Within
the same run it can pipet the solutions to be tested into test tubes
whilst putting an aliquot aside for archiving f.i. to build up a
serotheque). The system.can also be used to draw any combination
of aliquots flora primary tubes into secondary tubes (any size),
which then could be used by di.rent other analysers.
the liquid flowing up the cavity and around the tip cleans
its outside part. In the case of very adhesive solutions, a
decontaminating intermediate washing step can be pro-
grammed. Whole microtitration plates, or plates partly
filled with strips or individual wells, are loaded through
an access-controlled loading port. For additional safety,
the user has only limited access to the machine once a
run has started (access is allowed upon request only and
all moving parts of the system will stop). All this reduces
user interference, which is a very significant cause of
failures. Reducing user interference to the necessary
minimum was considered essential.R. Jakob and D. J. Vonderschmitt Development of a user-oriented completely open in vitro diagnostics system
Legend:
1. Pipetting tubing
2. Precision pumps
3. Top safety panel
4. Wash liquid containers
5. Room temperature incubator
6. Access door lock
7. Washer
8. Reader
9. Incubator with optional shaker
10. Robotic Manipulator arm (RoMa)
11. Access door
12. Worktable
13. Positive identification (PoslD)
14. Shelf
15. Liquid handling arm
Figure 3. The GEJVESIS RIP (presented is the 150 model). The worktable containingprimary tubes, wash station and various carriers
for microtitration plates and reagents is empty in this diagram.R. Jakob and D. J. Vonderschmitt Development of a user-oriented completely open in vitro diagnostics system
The loading port (up to six plates can be processed at the
same time) also serves as a darkened room temperature
incubator, whereas the adjustable temperature incubator
situated in the back of the machine (six individually
heatable slots from room temperature 4-5C up to 45C)
is also a linear shaker (1 to 8.2 Hz, mm amplitude).
This double function saves space and helped to reduce
the analyser size to bench-top.
Exclusion of possible failure sources demands positive
identification or better permanent identification [10] of
samples and reagents. A laser bar-code scanner auto-
matically reads the corresponding sample and reagent IDs
and checks the correct worktable configuration. Conse-
quently, the location of samples, processed samples, kits
and global reagents are stored in a system data base
log-file.
Additional safety is gained from automated clot-detection.
The user can also opt for a photometric liquid dispense
check if colour-coded reagents are used. This kind of
automatic system check is important because of the ever
growing legal consequences of product liability [11].
The user interface to the system is a Windows NT(R) based
software that guides the user step by step through: set-up,
service, method implementation, runs, data validation
and evaluation, data export and data import. A log-file
of all test specific data generated during a run is stored
in the analyser’s data-base, including eventual error
messages and causes, again to comply with regulations.
There is a scheduler in the software which determines the
times necessary for the various dilution, pipetting,
incubation, washing and reading steps for each test and
then combines them to minimize overall run time. Up to
six plates can be scheduled at the same time. Beta-site
testing was done with a fixed scheduler (each panel of
tests needs the same fixed maximal time span regardless
ofthe number ofsamples processed). This fixed (simplified)
scheduler should not influence the system performance,
but it allowed /?-testing to begin several months before
the final software was released. As is often the case, the
software development was behind schedule since the
implementation of all the complex functions of the system
demanded extensive programming resources.
System integration
About 10 years ago, the first dedicated systems for
automatic analysis with immunologic methods came onto
the market. Today a considerable number of such systems
with different test menus are commercially available (for
example Tosoh AIA systems, ACS 180, Boehringer ES
systems, Access, Axsym, Vidas, Autodelfia, COBAS
CORE, Elecsys [12]). Test menus are offered according
to the importance of bulk analysis and depending on the
availability of reliable test methods. Test panels for
thyroid function, fertility, tumour markers, serology and
drugs of abuse are the most common panels, but no single
instrument covers the whole programme. Tests with lower
test frequency are executed manually or assisted by some
kind of liquid sample handling systems.
Dedicated systems, as a rule, handle only one measuring
protocol. An open system, however, is designed to be more
flexible and to allow for a large number of different
protocols to be executed (different reagents, different
MTP formats, different washing solutions, incubation
times, wavelengths etc.). The price for this is often a
low-speed system compared to closed systems [13].
However, the user does not have to supervise the system
and can do something else during this time.
In dedicated systems, reagents and hardware are often
otpimized to exclude competitors’ reagents and tests. In
closed systems, reagents and consumables are matched to
the machine. In this way, companies can pay off their
investments in the development of an instrument through
marketing and sale of reagents and consumables. Com-
pletely open systems, on the other hand, handle tests from
different manufacturers and are freely programmable. A
robotic manipulator acting in a Cartesian coordinate
system has access to virtually every point of the usable
workspace of the system or analyser. This allows for
modular design according to the needs of the customer.
While dedicated systems, for economic reasons, are
optimized to large volume parameters, open systems are
not. In fact, it is easy to develop tests and run them on
an open system.
In dedicated systems, the client is totally dependent on
the manufactuer’s strategy and ability to develop or
supply new tests quickly. Some suppliers will not provide
some parameters (for example serology) and in other cases
only parts of a panel are realized (especially often within
the thyroid function panel and the cardiac parameters).
In the case of test supply problems (back order), the user
has to look for quick alternatives. All this clearly limits
the usefulness of closed systems for small laboratories.
Completely open systems are certainly more complex than
dedicated systems, some of which resemble ’black boxes’
with only a few buttons or keys to press and with very
limited or no access to the mechanical and electronic parts.
The complexity of open systems, however, is reduced
through user-friendly software:
The user is guided through the system and application
by an intuitive software and graphical user-interface.
(2) Programming of test procedures has to be done just
once during the system implementation and set-up
procedure. During routine use operator interaction
via display is generally reduced to pushing a few keys
or a few mouse clicks.
Manual and semi-automated techniques can, therefore,
be replaced by completely automated open systems that
show the same comfort as dedicated systems. The
detection system can be upgraded and could contain
detectors working with fluorimetry, time-resolved fluori-
metry and luminometry. Even the format of the reaction
vessels is not fixed to the microtitration plate format, since
the robotic manipulator can potentially handle a large
variety of recipients.
Future development
The pace at which immunologic tests develop depends
partly on methods being available to produce monoclonal
antibodies and available recombinant proteins. TheR. Jakob and D. J. Vonderschrnltt Development of a user-oriented completely open in vitro diagnostics system
number of both capture proteins is constantly increasing,
opening the way to low volume testing of even the most
special analytes. Although the MTP technique was
originally thought to be for tests that yield either a positive
or negative result, the current state of the art allows
quantification. Not only has the number of proteins
increased but so have the number of measuring tech-
niques. ELISA tests with coloured products are widely
used but more sensitive luminescent and fluorescent (for
example TRFIA) markers are taking their share of the
market. More recently, microtitration-plate based DNA
analysis has been developed for clinical diagnostics [-14].
The chief advantage of the system described in this paper
is its flexibility. Conventional automatic equipment
contains fixed programmes and fixed system layout and
cannot be easily adapted to new techniques. A robotic
equipment, however, is able to accommodate new and
different peripheral devices. The robotic manipulator
allows for a great variety of handling procedures within
the analytical process and can thus be dedicated to new
technologies and needs as they evolve, for instance when
the classical and somewhat arbitrary [15] 96-well
microtitration plate format will be replaced in the future
by carriers of higher capacity and platforms for multiple
analyte binding assays.
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